Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis

American Journal of Clinical Nutrition

Volumn 64, Issue 1, 1996, Pages 87-93

  Lepage, Guy ^a   Champagne, Josée ^b   Ronco, Nancy ^b   Lamarre, André ^b   Osberg, Iris ^b   Sokol, Ronald J ^b   Roy, Claude C ^b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b NONE

Author keywords

all rac tocopherol; ant ioxidants; carotenoids; cystic fibrosis; free radicals; Lipid peroxidation; malondialdehyde; oxidant stress; carotene

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; BIOCHEMICAL MARKER; CAROTENOID; FREE RADICAL; MALONALDEHYDE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; FEMALE; HUMAN; LEUKOCYTE ACTIVATION; LIPID PEROXIDATION; LUNG DISEASE; LUNG LAVAGE; MALE; OXIDATIVE STRESS; VITAMIN METABOLISM;

FORMICIDAE;

EID: 0029901789     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/64.1.87     Document Type: Article

References (62)

1. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993;57(suppl):715S-25S.
2. Homnick DN, Cox JH, DeLoof MJ, Ringer TV. Carotenoid levels in normal children and in children with cystic fibrosis. J Pediatr 1993; 122:703-7.
3. Salh B, Webb K, Guyan PM, et al. Aberrant free radical activity in cystic fibrosis. Clin Chim Acta 1989;181:65-74.
4. Richard MJ, Aguilaniu B, Arnaud J, Gout JP, Favier A. Selenium and oxidant injury in patients with cystic fibrosis. In: Emerit I, Packer L, Auclair C, eds. Antioxidants in therapy and preventive medicine. New York: Plenum Press, 1990:175-8.
5. Lepage G, Kneepkens CMF, Smith L, et al. Low beta-carotene may contribute to the accumulation of free radicals in cystic fibrosis (CF). FASEB J 1991;5:1075(abstr).
6. Bilton D, Maddison J, Webb AK, Seabra L, Jones M, Braganza JM. Cystic fibrosis, breath pentane, and lipid peroxidation. Lancet 1991; 337:1420(letter).
7. Winklhofer-Roob BM. Oxygen free radicals and antioxidants in cystic fibrosis: the concept of an oxidant-antioxidant imbalance. Acta Paediatr Suppl 1994;395:49-57.
8. Roum JH, Buhl R, McElvaney NG, Borok Z, Crystal RG. Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol 1993;75: 2419-24.
9. Langley SC, Brown RK, Kelly FJ. Reduced free-radical-trapping capacity and altered plasma antioxidant status in cystic fibrosis. Pediatr Res 1993;33:247-50.
10. Brown RK, Kelly FJ. Evidence for increased oxidative damage in patients with cystic fibrosis. Pediatr Res 1994;36:487-93.
11. Kharazmi A, Rechnitzer C, Schiotz PO, Jensen T, Baek L, Hoiby N. Priming of neutrophils for enhanced oxidative burst by sputum from cystic fibrosis patients with Pseudomonas aeruginosa infection. Eur J Biochem 1987;17:256-61.
12. Gilljam H, Strandvik B, Ellin A, Wiman LG. Increased mole fraction of arachidonic acid in bronchial phospholipids in patients with cystic fibrosis. Scand J Clin Lab Invest 1986;46:511-8.
13. Konstan MW, Byard PJ, Hoppel CL, Davis PB. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 1995;332: 848-54.
14. Holsclaw DS. Cystic fibrosis and pulmonary involvement from multiple perspectives. Semin Respir Infect 1993;7:141-50.
15. Babior BM. The respiratory burst oxidase. Trends Biomed Sci 1987; 12:241-3.
16. Britigan BE, Roeder TL, Rasmussen GT, Shasby DM, McCormick ML, Cox CD. Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells. J Clin Invest 1992;90: 2187-96.
17. Portal BC, Richard MJ, Faure HS, Hadjian AJ, Favier AE. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 1995;61:843-7.
18. Matkovics B, Gyurkovits K, Laszlo A, Szabo L. Altered peroxide metabolism in erythrocytes from children with cystic fibrosis. Clin Chim Acta 1982;125:59-62.
19. Sokol RJ, Reardon MC, Accurso FJ, et al. Fat-soluble-vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns. Am J Clin Nutr 1989;50:1064-71.
20. Ringer TV, DeLoof MJ, Cox JH, Homnick DN. Carotenoid levels in cystic fibrosis and healthy children. Pediatr Res 1991;29:376(abstr).
21. Lepage G, Ronco N, Champagne J, Lamarre A, Roy CC. Beta-carotene inhibits lipid peroxidation and improves peroxisomal function in cystic fibrosis (CF). FASEB J 1993;7:39(abstr).
22. Krinsky NI. Actions of carotenoids in biological systems. Annu Rev Nutr 1993;13:561-87.
23. van de Kamer JH, ten Bokkel Huinink H, Weijers HA. A rapid method for the determination of fat in faeces. J Biol Chem 1949; 177:347-55.
24. Lepage G, Munoz G, Champagne J, Roy CC. Preparative steps necessary for the accurate measurement of malondialdehyde by high-performance liquid chromatography. Anal Biochem 1991;197: 277-83.
25. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 1986;27:114-20.
26. Lepage G, Roy CC. Specific methylation of plasma nonesterified fatty acids in a one-step reaction. J Lipid Res 1988;29:227-35.
27. Dixon WJ, Massey FJ Jr. Introduction to statistical analysis. 3rd ed. Toronto: McGraw-Hill Book Co, 1969.
28. Brown RK, Kelly FJ. Role of free radicals in the pathogenesis of cystic fibrosis. Thorax 1994;49:738-42.
29. Homnick DN, Spillers CR, Cox SR, et al. Single- and multiple-dose response relationships of beta-carotene in cystic fibrosis. J Pediatr 1995;127:491-4.
30. 4. Lancet 1993;342: 465-9.
31. Wong JW, Ebeler SE, Rivkah-Isseroff R, Schibamoto T. Analysis of malondialdehyde in biological samples by capillary gas chromatography. Anal Biochem 1994;220:73-81.
32. Drapper HH, Squires EJ, Mahmoodi H, Wu J, Agarwal S, Hadley M. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med 1993;15:353-63.
33. Kappus H. Lipid peroxidation: mechanism and biological relevance. In: Aruoma OI, Halliwell B, eds. Free radicals and food additives. London: Taylor & Francis, 1991:59-75.
34. Sinnhuber RO, Yu TC. 2-Thiobarbituric acid method for the measurement of rancidity in fishery products: II. The quantitative determination of malondialdehyde. Food Technol 1958;12:9-12.
35. Lloyd-Still JD, Johnson SB, Holman RT. Essential fatty acid status in cystic fibrosis and the effects of safflower oil supplementation. Am J Clin Nutr 1981;34:1-7.
36. Landon C, Kerner JA, Castillo R, Adams L, Whalen R, Lewiston NJ. Oral correction of essential fatty acid deficiency in cystic fibrosis. JPEN J Parenter Enterai Nutr 1981;5:501-4.
37. Parsons HG, Shillabeer G, Rademaker AW. Early onset of essential fatty acid deficiency in patients with cystic fibrosis receiving a semi-synthetic diet. J Pediatr 1984;105:958-61.
38. Strandvik B, Bronnegard M, Gilljam H, Carlstedt-Duke J. Relation between defective regulation of arachidonic acid release and symptoms in cystic fibrosis. J Gastroenterol 1988;23(suppl 143):1-4.
39. Thompson GN. Relationships between essential fatty acid levels, pulmonary function and fat absorption in pre-adolescent cystic fibrosis children with good clinical scores. Eur J Pediatr 1989;148:327-9.
40. Strandvik B. Relation between essential fatty acid metabolism and gastrointestinal symptoms in cystic fibrosis. Acta Paediatr Scand Suppl 1989;363:58-65.
41. Lloyd-Still JD, Johnson SB, Holman RT. Essential fatty acid status and fluidity of plasma phospholipids in cystic fibrosis infants. Am J Clin Nutr 1991;54:1029-35.
42. Lepage G, Levy E, Ronco N, Smith L, Galeano N, Roy CC. Direct transesterification of plasma fatty acids for the diagnosis of essential fatty acid deficiency in cystic fibrosis. J Lipid Res 1989;30: 1483-90.
43. Dodge JA, Custance JM, Goodchild MC, Laing SC, Vaughan M. Paradoxical effects of essential fatty acid supplementation on lipid profiles and sweat electrolytes in cystic fibrosis. Br J Nutr 1990;63: 259-71.
44. Strandvik B, Berg U, Kallner A, Kusoffsky E. Effect on renal function of essential fatty acid supplementation in cystic fibrosis. J Pediatr 1989;115:242-50.
45. Holman RT. The ratio of trienoic:tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement. J Nutr 1960;70:405-10.
46. 13C-beta-carotene and high precision isotope ratio mass spectrometry. Ann N Y Acad Sci 1993;691:86-95.
47. Krasinski SD, Russell RM, Otradovec CL, et al. Relationship of vitamin A and vitamin E intake to fasting plasma retinol, retinol-binding protein, retinyl esters, carotene, α-tocopherol and cholesterol among elderly people and young adults: increased plasma retinyl esters among vitamin A-supplement users. Am J Clin Nutr 1989;49:112-20.
48. Krasinski SD, Cohn JS, Schaefer EJ, Russell RM. Postprandial plasma retinyl ester response is greater in older subjects compared with younger subjects. J Clin Invest 1990;85:883-92.
49. Smith FR, Goodman DS. Vitamin A transport in human vitamin A toxicity. N Engl J Med 1976;294:805-8.
50. Shapiro BL. Evidence for a mitochondrial lesion in cystic fibrosis. Life Sci 1989;44:1327-34.
51. Winklhofer-Roob BM. Oxygen free radicals and antioxidants in cystic fibrosis: the concept of an oxidant-antioxidant imbalance. Acta Paediatr Suppl 1994;395:49-57.
52. James DR, Alfaham M, Goodchild MC. Increased susceptibility to peroxide-induced haemolysis with normal vitamin E concentrations in cystic fibrosis. Clin Chim Acta 1991;204:279-90.
53. Burton GW, Ingold KU. Beta-carotene: an unusual type of lipid antioxidant. Science 1989;224:569-73.
54. Dixon ZR, Burri BJ, Clifford A, et al. Effects of a carotene-deficient diet on measures of oxidative susceptibility and superoxide dismutase activity in adult women. Free Radic Biol Med 1994;17:537-44.
55. Allard JP, Royall D, Kurian R, Muggli R, Jeejeebhoy KN. Effects of β-carotene supplementation on lipid peroxidation in humans. Am J Clin Nutr 1994;59:884-90.
56. Prabhala RH, Garewal HS, Hicks MJ, Sampliner RE, Watson RR. The effects of 13-cis-retinoic acid and beta-carotene on cellular immunity in humans. Cancer 1991;67:1556-60.
57. Daudu PA, Kelley DS, Taylor PC, Burri BJ, Wu MM. Effect of a low β-carotene diet on the immune functions of adult women. Am J Clin Nutr 1994;60:969-72.
58. Kennedy TA, Liebler DC. Peroxyl radical scavenging by β-carotene in lipid bilayers: effect of oxygen partial pressure. J Biol Chem 1992; 267:4658-63.
59. Jialal I, Grundy SM. Effects of dietary supplementation with α-tocopherol on the oxidative modification of low density lipoprotein. J Lipid Res 1992;33:899-906.
60. Leibovitz B, Hu ML, Tappel AL. Dietary supplements of vitamin E, β-carotene, coenzyme Q10 and selenium protect tissues against lipid peroxidation in rat tissue slices. J Nutr 1990;120:97-104.
61. Palozza P, Krinsky NI. β-carotene and alpha-tocopherol are synergistic antioxidants. Arch Biochem Biophys 1992;297:184-7.
62. Winklhofer-Roob BM, Puhl H, Khoschsorur G, Van't Hof MA, Esterbauer H, Shmerling DH. Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during β-carotene supplementation in cystic fibrosis. Free Radic Biol Med 1995;18:849-59.